GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cosmos Health Inc (NAS:COSM) » Definitions » Free Cash Flow per Share

Cosmos Health (Cosmos Health) Free Cash Flow per Share : $-2.95 (TTM As of Sep. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Cosmos Health Free Cash Flow per Share?

Cosmos Health's Free Cash Flow per Share for the three months ended in Sep. 2023 was $-0.53. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $-2.95.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 8.40% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the FCF Growth Rate using Free Cash Flow per Share data.

The historical rank and industry rank for Cosmos Health's Free Cash Flow per Share or its related term are showing as below:

COSM' s 3-Year FCF Growth Rate Range Over the Past 10 Years
Min: -79.9   Med: -25.8   Max: 8.4
Current: 8.4

During the past 13 years, Cosmos Health's highest 3-Year average Free Cash Flow per Share Growth Rate was 8.40% per year. The lowest was -79.90% per year. And the median was -25.80% per year.

COSM's 3-Year FCF Growth Rate is ranked worse than
50.85% of 59 companies
in the Medical Distribution industry
Industry Median: 8.4 vs COSM: 8.40

Cosmos Health Free Cash Flow per Share Historical Data

The historical data trend for Cosmos Health's Free Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmos Health Free Cash Flow per Share Chart

Cosmos Health Annual Data
Trend Jul13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Free Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.87 -10.29 -21.84 -12.16 -7.91

Cosmos Health Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Free Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.48 -0.98 -0.60 -0.85 -0.53

Competitive Comparison of Cosmos Health's Free Cash Flow per Share

For the Medical Distribution subindustry, Cosmos Health's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosmos Health's Price-to-Free-Cash-Flow Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cosmos Health's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cosmos Health's Price-to-Free-Cash-Flow falls into.



Cosmos Health Free Cash Flow per Share Calculation

Free Cashflow per Share is the amount of Free Cashflow per outstanding share of the company's stock.

Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company.

Note: GuruFocus does not calculate Free Cash Flow Per Share when Capital Expenditure is 0.

Cosmos Health's Free Cash Flow Per Share for the fiscal year that ended in Dec. 2022 is calculated as

Free Cash Flow Per Share(A: Dec. 2022 )
=(Cash Flow from Operations+Capital Expenditure)/Shares Outstanding (Diluted Average)
=(-14.871+-0.383)/1.928
=-15.254/1.928
=-7.91

Cosmos Health's Free Cash Flow Per Share for the quarter that ended in Sep. 2023 is calculated as

Free Cash Flow Per Share(Q: Sep. 2023 )
=(Cash Flow from Operations+Capital Expenditure)/Shares Outstanding (Diluted Average)
=(-4.524+-2.146)/12.585
=-6.67/12.585
=-0.53

Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cosmos Health  (NAS:COSM) Free Cash Flow per Share Explanation

Free Cash Flow is very close to Warren Buffett's definition of Owner's Earnings, except that in Warren Buffett's Owner's Earnings, the spending for Property, Plant, and Equipment is only for maintenance (replacement), while in the Free Cash Flow calculation, the cost of new Property, Plant, and Equipment due to business expansion is also deducted. There, Free Cash Flow is more conservative than Owner's Earnings.

In Don Yacktman's calculation of forward rate of return, he uses Free Cash Flow for the calculation. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation.

This is what Yacktman said in his March 2012 interview - when the S&P 500 was at 1400:

If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.

The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).

For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over seven years. The reason we use seven years is because research shows that seven years is the length of the typical business cycle.

Therefore, as of Dec22, Cosmos Health's Forward Rate of Return (Yacktman) % is

Forward Rate of Return (Yacktman) % (Dec22)=Normalized Free Cash Flow/Price+5-Year EBITDA Growth Rate
=0/1.57+0
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Free Cash Flow within a report period can be affected by management's decisions of capital spending. Therefore, it is important to look at long term when it comes to Free Cash Flow.


Cosmos Health Free Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Cosmos Health's Free Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosmos Health (Cosmos Health) Business Description

Traded in Other Exchanges
Address
141 West Jackson Boulevard, Suite 4236, Chicago, IL, USA, 60604
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers.
Executives
Grigorios Siokas 10 percent owner 5 AG. GEORGIOU STR., PILEA, THESSALONIKI J3 TK57001
Suhel Bhutawala director 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Nikolaos Bardakis officer: Chief Operating Officer 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Manfred Ziegler director 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Anastasios Aslidis director 11 CANTERBURY LANE, WATCHUNG NJ 07069
Pavlos Ignatiades officer: Chief Operating Officer KALAPATHAKI 5, PANORAMA, THESSALONIKI J3 55236
Georgios Terzis officer: Chief Financial Officer 2 MELITOS STR., NEA SMIRNI, ATTICA J3 17121
Peter Goldstein director 151 NORTH NOB HILL ROAD SUITE 321, FORT LAUDERDALE FL 33324
John James Hoidas director 9301 S. HARLEM AVENUE, OAK LAWN, CHICAGO IL 60453
Dimitrios Goulielmos director, 10 percent owner, officer: CEO 141 WEST JACKSON BLVD, SUITE 4236, CHICAGO IL 60604
Panagiotis Tolis director, officer: Secretary PERICLEOUS 50 STREET, ATHENS J3 15232
Panagiotis Drakopoulos director, 10 percent owner, officer: CEO 200 SOUTH WACKER DRIVE, SUITE 300, CHICAGO IL 60606
Vasileios Mavrogiannis director, 10 percent owner, officer: CFO TERTSETI 23 STREET, KESARIANI J3 16122